Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events
The advent of immune checkpoint inhibitors (ICIs) has significantly transformed cancer treatment outcomes. However, these therapies can induce immune-related adverse events (irAEs) that may affect any organ system, sometimes requiring specialized expertise. As ICIs are increasingly used across vario...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/32/3/140 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849342055965261824 |
|---|---|
| author | Khashayar Esfahani John Walker Kevin Bambury Eoin O’Carroll Stephanie Snow |
| author_facet | Khashayar Esfahani John Walker Kevin Bambury Eoin O’Carroll Stephanie Snow |
| author_sort | Khashayar Esfahani |
| collection | DOAJ |
| description | The advent of immune checkpoint inhibitors (ICIs) has significantly transformed cancer treatment outcomes. However, these therapies can induce immune-related adverse events (irAEs) that may affect any organ system, sometimes requiring specialized expertise. As ICIs are increasingly used across various tumor types and in earlier treatment settings, not all practitioners have the necessary support network to handle complex irAEs. To address this gap, we collaborated with ONCOassist, a leading app for oncology professionals, to establish the first virtual Canadian Community of Practice (CoP) focused on irAEs. The CoP facilitates continuous learning and improves patient care among Canadian clinicians treating patients with immunotherapy by providing a platform for knowledge exchange and peer-to-peer support. This article outlines the development and growth of the CoP on irAEs, highlighting both successes and challenges. As of May 2024, over a year since its inception, the CoP on irAEs has attracted almost 130 Canadian oncology healthcare professionals, and peer-to-peer interactions and engagement continue to increase. To ensure its long-term sustainability, we plan to evolve and adapt the CoP to meet the needs of the oncology community and address clinical challenges associated with new therapies. |
| format | Article |
| id | doaj-art-4c68c9809d934f0487db77e87bb3f4bb |
| institution | Kabale University |
| issn | 1198-0052 1718-7729 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Current Oncology |
| spelling | doaj-art-4c68c9809d934f0487db77e87bb3f4bb2025-08-20T03:43:30ZengMDPI AGCurrent Oncology1198-00521718-77292025-02-0132314010.3390/curroncol32030140Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse EventsKhashayar Esfahani0John Walker1Kevin Bambury2Eoin O’Carroll3Stephanie Snow4Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, CanadaCross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, CanadaONCOassist, V93 T8K7 Killarney, IrelandONCOassist, V93 T8K7 Killarney, IrelandQEII Health Sciences Centre, Dalhousie University, Halifax, NS B3H 1V8, CanadaThe advent of immune checkpoint inhibitors (ICIs) has significantly transformed cancer treatment outcomes. However, these therapies can induce immune-related adverse events (irAEs) that may affect any organ system, sometimes requiring specialized expertise. As ICIs are increasingly used across various tumor types and in earlier treatment settings, not all practitioners have the necessary support network to handle complex irAEs. To address this gap, we collaborated with ONCOassist, a leading app for oncology professionals, to establish the first virtual Canadian Community of Practice (CoP) focused on irAEs. The CoP facilitates continuous learning and improves patient care among Canadian clinicians treating patients with immunotherapy by providing a platform for knowledge exchange and peer-to-peer support. This article outlines the development and growth of the CoP on irAEs, highlighting both successes and challenges. As of May 2024, over a year since its inception, the CoP on irAEs has attracted almost 130 Canadian oncology healthcare professionals, and peer-to-peer interactions and engagement continue to increase. To ensure its long-term sustainability, we plan to evolve and adapt the CoP to meet the needs of the oncology community and address clinical challenges associated with new therapies.https://www.mdpi.com/1718-7729/32/3/140irAEimmune checkpoint inhibitorcommunity of practicemobile application |
| spellingShingle | Khashayar Esfahani John Walker Kevin Bambury Eoin O’Carroll Stephanie Snow Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events Current Oncology irAE immune checkpoint inhibitor community of practice mobile application |
| title | Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events |
| title_full | Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events |
| title_fullStr | Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events |
| title_full_unstemmed | Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events |
| title_short | Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events |
| title_sort | enhancing care through a virtual canadian community of practice for managing immune related adverse events |
| topic | irAE immune checkpoint inhibitor community of practice mobile application |
| url | https://www.mdpi.com/1718-7729/32/3/140 |
| work_keys_str_mv | AT khashayaresfahani enhancingcarethroughavirtualcanadiancommunityofpracticeformanagingimmunerelatedadverseevents AT johnwalker enhancingcarethroughavirtualcanadiancommunityofpracticeformanagingimmunerelatedadverseevents AT kevinbambury enhancingcarethroughavirtualcanadiancommunityofpracticeformanagingimmunerelatedadverseevents AT eoinocarroll enhancingcarethroughavirtualcanadiancommunityofpracticeformanagingimmunerelatedadverseevents AT stephaniesnow enhancingcarethroughavirtualcanadiancommunityofpracticeformanagingimmunerelatedadverseevents |